This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Apotex Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Krishna Hari Bhandari
Introduction
Krishna Hari Bhandari is a notable inventor based in Brampton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly with his work on oxcarbazepine. His innovative approach has led to the development of extended release dosage forms that enhance the efficacy of this medication.
Latest Patents
One of his key patents is for the "Oxcarbazepine extended release dosage form." This invention relates to the formulation of extended release pharmaceutical dosage forms of oxcarbazepine, which is used to treat epilepsy and other conditions. The patent showcases his commitment to improving patient care through innovative drug delivery systems. He holds 1 patent in this area.
Career Highlights
Krishna is currently employed at Apotex Inc., a leading pharmaceutical company known for its commitment to quality and innovation. His role at Apotex allows him to work on cutting-edge pharmaceutical developments, contributing to the company's mission of providing affordable medications to patients worldwide.
Collaborations
Throughout his career, Krishna has collaborated with several talented individuals, including Navin Vaya and Bernard Charles Sherman. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
In summary, Krishna Hari Bhandari is a dedicated inventor whose work in the pharmaceutical industry has led to significant advancements in drug formulation. His contributions, particularly in the area of oxcarbazepine, highlight the importance of innovation in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
